| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 76,836 | 77,471 | 78,944 | 79,387 | | Cost of Revenue | 52,768 | 51,357 | 53,868 | 53,867 | | | Gross Profit | 24,068 | 26,114 | 25,076 | 25,520 | | | Operating Expenses | | Research Development | 2,439 | 2,380 | 2,416 | 3,346 | | Selling General and Administrative | 7,930 | 7,312 | 10,577 | 12,904 | | Non Recurring | 1,863 | 11,273 | 785 | 84,370 | | Others | 3,715 | 4,173 | 4,063 | 4,458 | | | | Total Operating Expenses | 15,947 | 25,138 | 17,841 | 105,078 | | | | Operating Income or Loss | 8,121 | 976 | 7,235 | (79,558) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (65) | 19 | 46 | (163) | | Earnings Before Interest And Taxes | 10,246 | 1,351 | 7,353 | (79,685) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 10,246 | 1,351 | 7,353 | (79,685) | | Income Tax Expense | 542 | 515 | 499 | (19,234) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,286 | 836 | 6,854 | (60,451) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,704 | 836 | 6,854 | (60,451) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,704 | $836 | $6,854 | ($60,451) |
|
0.51% Nasdaq 
0.16 (2.12%) 
Income Statement
